Previous 10 | Next 10 |
home / stock / mvmdf / mvmdf news
TORONTO, May 18, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “ Company ” or “ MVMD ”) (CSE: MVMD) (FRA:20MP) is pleased to announce it has received its third-party Bio Safety Level 4 (“BSL-4”) lab study results from it...
Mountain Valley MD Provides Update on Current Trials Canada NewsWire TORONTO , May 11, 2021 /CNW/ - Mountain Valley MD Holdings Inc. (the " Company " or " MVMD ") (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to provide an update on current pre-cl...
Mountain Valley MD Holdings ([[MVMDF]]) has filed a novel cancer adjuvant patent and is proceeding with pre-clinical trials in triple-negative breast cancer, metastatic melanoma, and lung carcinoma.The patent-pending adjuvant utilizes the company's advances in macrocyclic lactone solubility t...
Mountain Valley MD Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Patent Canada NewsWire Ivectosol™ being tested to target certain cancers to pursue novel human intratumoral injection and intravenous infusion TORONTO , May 3...
Mountain Valley MD Holdings Inc. Proceeding with Application to List on the TSX Venture Exchange Canada NewsWire TORONTO , April 20, 2021 /CNW/ - Mountain Valley MD Holdings Inc. (the " Company " or " MVMD ") (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) ...
Mountain Valley MD (MVMDF) fell 3% after Night Market Research released a new short report on the company, seeing potential 100% downside.Night Market highlights how the company has shifted from cannabis, to nutraceuticals, to pharmaceuticals and to Covid all within less than a year.Nigh...
Mountain Valley MD pivots between hype-filled sectors in quick succession. Previous iteration as a cannabis operation ended with assets incurring near complete losses totalling over C$10m. Less than a year later, Mountain Valley now claims to have developed technologies capable of rev...
Mountain Valley MD Commencing Trials in Bangladesh, Striking Pharmaceutical Production Agreements Canada NewsWire TORONTO , March 16, 2021 /CNW/ - Mountain Valley MD Holdings Inc. (the " Company " or " MVMD ") (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is...
Mountain Valley MD Achieves Solubilization of Selamectin, Files Trademark For Selactosol™ Canada NewsWire TORONTO , March 10, 2021 /CNW/ - Mountain Valley MD Holdings Inc. (the " Company " or " MVMD ") (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is ...
Mountain Valley MD Proceeding with FDA 505(b)(2) Pathway Application for Novel Ivectosol™ Canada NewsWire And provides update on its BSL-4 and Dose Sparing Adjuvant Trials TORONTO , March 3, 2021 /CNW/ - Mountain Valley MD Holding...
News, Short Squeeze, Breakout and More Instantly...
Mountain Valley MD Holdings Inc Company Name:
MVMDF Stock Symbol:
OTCMKTS Market:
Mountain Valley MD Holdings Inc Website:
Mountain Valley MD Holdings Inc (MVMDF) is expected to report for Q2 2022
Mountain Valley MD Holdings Inc. (the “ Company ” or “ MVMD ”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce that it has executed an Amended and Restated Supply and License Agreement (the “ Agreement ”) with Agrarius Corp. (&...
Mountain Valley MD Holdings Inc. (the “ Company ” or “ MVMD ”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to provide a broad business update of its progress across its three core lines of business: Nutraceuticals - novel innovations through t...